|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/22 | |
| C07K 16/28 | |||
| A61K 39/00 |
| (11) | Number of the document | 3277716 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16763992.1 |
| Date of filing the European patent application | 2016-04-03 | |
| (97) | Date of publication of the European application | 2018-02-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-06-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/025802 |
| Date | 2016-04-03 |
| (87) | Number | WO 2016/161410 |
| Date | 2016-10-06 |
| (30) | Number | Date | Country code |
| 201562143016 P | 2015-04-03 | US | |
| 201562191797 P | 2015-07-13 | US |
| (72) |
MIRZA, Amer, M., US
AKHURST, Rosemary, J., US
LI, Ou, US
|
| (73) |
The Regents of the University of California,
1111 Franklin Street, 12th Floor, Oakland, CA 94607,
US
XOMA Technology Ltd., 2910 Seventh Street, Berkeley, CA 94710, US |
| (54) | TREATMENT OF CANCER USING INHIBITORS OF TGF-BETA AND PD-1 |
| TREATMENT OF CANCER USING INHIBITORS OF TGF-BETA AND PD-1 |